Allonix Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Allonix Therapeutics General Information

Description

Developer of small-molecule drugs designed to treat ulcerative colitis. The company is researching a cell-signaling pathway involved in inflammation, cholesterol homeostasis, and cellular metabolism, enabling customers to receive localized steroid treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 201 East 5th Street
  • Suite 2505
  • Cincinnati, OH 45202
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 201 East 5th Street
  • Suite 2505
  • Cincinnati, OH 45202
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allonix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 01-Jan-2025 Completed Pre-Clinical Trials
3. Accelerator/Incubator 13-Mar-2024 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Sep-2023 Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2023 Completed Pre-Clinical Trials
To view Allonix Therapeutics’s complete valuation and funding history, request access »

Allonix Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allonix Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Georgia Research Alliance Not-For-Profit Venture Capital Minority
Orange Grove Bio Venture Capital Minority
Crohn's & Colitis Foundation Limited Partner
Biolocity Accelerator/Incubator
Emory University University
To view Allonix Therapeutics’s complete investors history, request access »

Allonix Therapeutics FAQs

  • When was Allonix Therapeutics founded?

    Allonix Therapeutics was founded in 2023.

  • Where is Allonix Therapeutics headquartered?

    Allonix Therapeutics is headquartered in Cincinnati, OH.

  • What is the size of Allonix Therapeutics?

    Allonix Therapeutics has 9 total employees.

  • What industry is Allonix Therapeutics in?

    Allonix Therapeutics’s primary industry is Drug Discovery.

  • Is Allonix Therapeutics a private or public company?

    Allonix Therapeutics is a Private company.

  • What is Allonix Therapeutics’s current revenue?

    The current revenue for Allonix Therapeutics is .

  • Who are Allonix Therapeutics’s investors?

    Georgia Research Alliance, Orange Grove Bio, Crohn's & Colitis Foundation, Biolocity, and Emory University have invested in Allonix Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process